Quell Therapeutics Announces Presentation at Oppenheimer's 3

/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), a world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical...

Related Keywords

Boston , Massachusetts , United States , London , City Of , United Kingdom , Eleanor Perkin , Frazer Hall , Luke Henry , Christina Tartaglia , Therapeutics Ltd , Quell Therapeutics Ltd , Annual Oppenheimer Healthcare Conference , Chief Business , Mark Swallow , Quell Therapeutics ,